RBC8 2 mg | 99.81%
TargetMol
RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
More Information Supplier PageRBC8
Search Results
RBC8 10 mg | 99.81%
TargetMol
RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
More Information Supplier PageRBC8
RBC8 25 mg | 99.81%
TargetMol
RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
More Information Supplier PageRBC8
RBC8 50 mg | 99.81%
TargetMol
RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
More Information Supplier PageRBC8
Retapamulin 5 mg | 99.82%
TargetMol
Retapamulin, a Pleuromutilin Antibacterial, binds to both E. coli and S. aureus ribosomes with similar potencies (Kd: 3 nM).
More Information Supplier PageRetapamulin
SB-705498 1 mg | 98.00%
TargetMol
SB705498 is a TRPV1 antagonist for hTRPV1. SB-705498 has been investigated for the treatment of Rhinitis, Chronic Cough, and Non-allergic Rhinitis.
More Information Supplier PageSB-705498
Sirtinol 25 mg | 99.75%
TargetMol
Sirtinol
Clinofibrate 100 mg | Purity Not Available
TargetMol
Clinofibrate（IC50 of 0.47 mM）, a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood.
More Information Supplier PageClinofibrate
Clinofibrate 25 mg | Purity Not Available
TargetMol
Clinofibrate（IC50 of 0.47 mM）, a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood.
More Information Supplier PageClinofibrate
Brimonidine Tartrate 100 mg | 99.83%
TargetMol
Brimonidine Tartrate (AGN190342 tartrate) is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.
More Information Supplier PageBrimonidine Tartrate
